InvestorsHub Logo
icon url

jessellivermore

04/02/19 4:16 PM

#185039 RE: jessellivermore #185029

rfj....

Alright...I actually looked up the Furosemide on the FDA's website and guess what...The FDA approved Furosemide on July ! 1966...

According to the label Furosemide is a diuretic whose primary indication in peds and adults is edema related to congestive heart failure...The label reads.


"Lasix is indicated in adults and pediatric patients for the treatment of edema associated with congestive
heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Lasix is
particularly useful when an agent with greater diuretic potential is desired."

https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/016273s061lbl.pdf

Nice try...welcome to ignore...

":>) JL
icon url

rfj1862

04/02/19 4:36 PM

#185050 RE: jessellivermore #185029

Adding a new therapeutic agent which is a novel way to approach a well understood disease is different than adding a new diuretic to treat a disease where everyone understands diuretics are beneficial.



That's a good point and you may be right for cardiovascular medicine.

In cancer (which is what I know best these days; I stopped working on Lipitor when it went off patent) it is pretty routine to add novel MOA drugs to standard of care before they ever get approval for a specific indication.